COUSI INVEST AS • 993511749 • Oslo

This website uses cookies to enhance the user experience.

||

COUSI INVEST AS

Organization

Chairman of the board: JP
Jan Petter Wilhelm Courvoisier Sissener1955
Years since formation: 16 years; since Jan 12, 2009
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 2,000; 2 share classes
Total number of shareholders: 4; persons
Belongs to group of

Financials

Annual total result 2024: -12,374,747; NOK
Total equity 2024: 90,667,629; NOK

Last update: Sep 9, 2025

Management

Board

Name	Role	Shares
JP Jan Petter Wilhelm Courvoisier Sissener 1955	Contact Person, Chairman	50.5 % directly
HS Helle Sissener 1956	Alternate Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
JP Jan Petter Wilhelm Courvoisier Sissener 1955	Contact Person, Chairman	50.5 % directly
JP Jan Philippe Courvoisier Sissener 1986	-	16.5 % directly
EC Ellen Caroline Courvoisier Sissener 1983	-	16.5 % directly
MA Maria Alexandra Courvoisier Sissener Steen 1990	-	16.5 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
JP Jan Petter Wilhelm Courvoisier Sissener 1955	A-shares	1,010	50.5 %
EC Ellen Caroline Courvoisier Sissener 1983	Class B shares	330	16.5 %
JP Jan Philippe Courvoisier Sissener 1986	Class B shares	330	16.5 %
MA Maria Alexandra Courvoisier Sissener Steen 1990	Class B shares	330	16.5 %

Shares owned by the COUSI INVEST AS

Name	Share class	Total number of shares	Share
M MELKEVEIEN 15 AS	Ordinary shares	100,000	100 %
S SIRIUS SECURITIES AS	Ordinary shares	3,000	100 %
S SISSENER AS	A-shares	555,000	92.5 %
V VILLA UTSIKTEN FRILUFTS- OG IDRETTSBARNEHAGE AS	Ordinary shares	18	90 %
R RYGGE AIRPORT AS	Ordinary shares	50,000	3.52 %
T TOPCAMP AS	NO0010781602	54,000	0.97 %
A AMICOAT AS	NO0010799679	335,497	0.87 %
L LYTIX BIOPHARMA AS	NO0010405780	130,132	0.19 %
S SAFE4 SECURITY GROUP AS	NO0010840564	2,150	0.16 %
P PHARMASUM THERAPEUTICS AS	Ordinary shares	1,024	0.03 %
P PHARMA HOLDINGS AS	NO0010797350	217	0.02 %
A ARRIBATEC GROUP ASA	NO0012861667	2,977	< 0.01 %

Last update: Jun 2, 2025

Group structure

COUSI INVEST AS
Total operating income 2024: NOK 0
Operating profit 2024: NOK -815,337
Employees: 0

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Annual Total Result	-12,374,747	18,985,046	8,872,331	26,597,060
Total assets	218,977,806	210,677,085	176,859,067	160,096,885
Total liabilities	128,310,177	98,634,709	71,741,737	63,851,886
Total equity	90,667,629	112,042,376	105,117,330	96,244,999

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Total operating costs	815,337	918,673	553,642	1,059,214
Operating result	-815,337	-918,673	-553,642	-1,059,214
Financial income/costs	-4,829,558	25,609,094	11,574,171	27,947,730
Profit before tax	-5,644,895	24,690,421	11,020,529	26,888,516
Total tax & extraordinary income/cost	6,729,852	5,705,375	2,148,198	291,456
Annual Total Result	-12,374,747	18,985,046	8,872,331	26,597,060

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	188,509,252	179,295,683	154,120,145	122,399,946
Total current assets	30,468,554	31,381,402	22,738,922	37,696,939
Total assets	218,977,806	210,677,085	176,859,067	160,096,885
Short term debt	49,071,452	20,447,724	1,236,457	10,437,301
Long term debt	79,238,725	78,186,985	70,505,280	53,414,585
Total liabilities	128,310,177	98,634,709	71,741,737	63,851,886
Contributed capital	5,988,711	5,988,711	12,048,711	12,048,711
Retained earnings	84,678,918	106,053,665	93,068,619	84,196,288
Total equity	90,667,629	112,042,376	105,117,330	96,244,999
Total equity and liabilities	218,977,806	210,677,085	176,859,067	160,096,885

Classification

Type of organization

Limited company